This project is part of the EDCTP2 Programme supported by the European Union.
This project is part of the EDCTP2 Programme supported by the European Union.
Meet four scientists contributing to the malaria elimination agenda and the future of African research through their work. Each of these scientists are also scholarship recipients from the EDCTP2-funded SINDOFO and PAMAfrica consortia.
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study
The Lancet infectious diseases
Peer reviewed article